Latest action: Read twice and referred to the Committee on the Judiciary.
Referred to one or more standing committees for review, hearings, and possible markup.
Specific committees not parsed from action data.
The committee may hold hearings, amend the bill, or let it die without action.
Next: Reported
Full chamber floor — Speaker / Majority Leader controls scheduling
Protects specialized infant formula supply and access for vulnerable infants.
The problem
Infants with severe allergies and medical conditions require specialized formulas. Supply disruptions or restrictions could endanger their health and development.
The proposal
Bill establishes protections for specialized infant formula availability and access. Likely includes safeguards against discontinuation or market restrictions of medically necessary formulas.
The impact
Families with medically fragile infants benefit from guaranteed formula access. Healthcare providers, formula manufacturers, and regulators are also affected by new requirements.
Ensures infants with severe allergies and medical conditions have reliable access to life-sustaining specialized formulas. Prevents dangerous gaps in supply that could harm their health.
Families caring for medically fragile infants face constant worry about formula availability. Legal protections provide peace of mind and stability.
Clear legal protections may incentivize manufacturers to produce specialized formulas. Creates more stable market conditions for niche medical products.
Consistent access to correct formula prevents malnutrition and medical emergencies. Supports normal development in vulnerable infants.
Protections requiring formula stockpiling or guaranteed production could raise prices. Costs may pass to consumers, insurance, or government programs.
Manufacturers face new compliance requirements and paperwork. Small producers may struggle with additional regulations.
Without full bill text, it's unclear which formulas qualify for protection. Definition disputes could leave some infants unprotected.
Government protections may distort free market competition. Could reduce innovation in formula development.
Generated by AI from the bill text. Not a prediction and not legal or policy advice. The percentage is the model's own rating of each item — self-reported, and not a measure of how accurate it is.
Loading map…
Loading...
0 citizens have already voted
Free · No spam · See how your representatives voted
Be the first to weigh in
Your vote starts the conversation
How citizen engagement works
Citizens vote & comment
Public opinion data is aggregated and updated in real time.
Patterns become visible
Representatives can see constituent sentiment broken down by district.
Your voice on the record
Contact your rep directly — one constituent call can shift a staffer's priority list.
Research shows that constituent contacts — especially calls — are among the most effective ways to influence a legislator's position on active bills.
Individual contributions, grouped by employer · FEC
Where their individual donors work · 2026 cycle
Money from people who work there, not from the company. Not tied to this bill.
Itemized individual contributions via FEC, grouped by the employer each contributor self-reported. Companies and unions cannot contribute to federal candidates from their treasuries, so these totals are money from people who work at an employer — never from the organization itself. They are campaign contributions covering a full election cycle and are not connected to this bill.
Senate LDA lobbying disclosures
Couldn't load lobbying disclosures right now.